BIOMEDevice Boston keynote speakers revealed
Thernaos whistleblower Erika Cheung, Segway inventor and cofounder Dean Kamen, and a panel from MedExecWomen all are special keynote speakers at BIOMEDevice Boston.
Slated to take place 28-29 September at the Boston Convention & Exhibition Center in Boston, these keynotes bring together the most respected minds and innovators in the biomedical device industry.
Erika Cheung now is the CEO of Ethics in Entrepreneurship, which helps businesses create a proactive ethical culture amongst startups. Her Day 1 keynote will focus on aiding future tech leaders to recognise and act when ethical problems arise within the industry. A former medical researcher turned technology and innovation ecosystem builder, Erika will recount her experience at Theranos and how to avoid the same ethical problems.
Dean Kamen will be on hand for the Day 1 afternoon session to detail his journey from patenting the first Segway model to building companies from the ground up. For Day 2, an exclusive panel put together by MedExecWomen will host a panel to discuss the keys to driving adoption of SaMD and digital solutions into medical practice.
“We are thrilled to have Erika, Dean and the MedExec Women panel presenting at BIOMEDevice Boston,” Adrienne Zepeda, group event director, BIOMEDevice Boston. “These keynotes will deliver unique insights into how to garner success in the medical device world through innovation, technology and ethics.”
Zepeda continued, “With the intense disruptions and changes that the medical market is facing, it’s important for startups and seasoned business owners to understand the trends with new and highly advanced technologies focus on prevention, wellness, diagnosis, and detection in the medical world. We believe these keynotes will be beneficial to everyone in the industry.”
Industry press are encouraged to register for BIOMEDevice Boston for the chance to tune into the keynote panel, which will be available both live on the show floor and online via the event’s digital platform.
28th September – Day 1
9:15-10:15 a.m. – Erika Cheung Keynote
10:30-11 a.m. – Q&A with Erika Cheung in the Start-up Stadium
12:30-1:15 p.m. – Dean Kamen Keynote
4-5 p.m. – Welcome reception with special guest, Erika Cheung
29th September – Day 2
9:15-10:15 a.m. – Keynote: At the Cutting Edge of Digital Health (Sponsored by MedExec Women)
Erika Cheung is the CEO and Executive Director of Ethics in Entrepreneurship, which is a non-profit organisation aimed at embedding ethical questioning, culture and systems in start-up companies. She was instrumental in bringing the malpractices at Theranos to light. She began her career in medical research and went on to help launch a technology accelerator in Hong Kong, supporting start-up organisations across the Asia-Pacific region. She hopes to use her story with Theranos as a cautionary tale for those breaking in to the biomedical space.
Dean Kamen, the co-founder and inventor of Segway, is an American engineer, inventor, and businessman. He holds more than 1000 U.S. and foreign patents, many of them for innovative medical devices that have expanded the frontiers of health care worldwide. Kamen is credited with designing the world’s first portable insulin pump for diabetics, founded DEKA Research & Development Corporation to develop internally generated inventions, and founded FIRST (For Inspiration and Recognition of Science and Technology), an organisation dedicated to motivating the next generation to understand, use and enjoy science and technology.
MedExecWomen is an organisation focused on empowering female executives to accelerate the positive impact of medical devices, diagnostics, drug delivery, and digital healthcare around the world. Comprised of a panel of the top female medical executives in the country, MedExecWomen’s mission is to increase the value brought to healthcare by female executives, strengthen future gender diversity though a connected, effective and visible female leadership pool, and support female executives as they navigate ambiguity and complexity to lead in rapidly changing markets.